RecruitingPhase not listed

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Blood draws, Questionnaires

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "The purpose of this research study is to test a new process for diagnosing lung cancer by examining changes to your DNA that can be detected from a blood test."
  • "Participants in this study will have blood samples collected, have their medical records reviewed by study personnel and fill out questionnaires at different time points during the study."
  • "Blood sample collection will occur during normal routine clinic visits."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests a new way to find lung cancer by looking for changes to DNA in a blood sample. It is for adults who get care at University of Maryland Baltimore Washington Medical Center. Taking part lasts about 5 years and includes blood tests at regular clinic visits, a review of medical records, and questionnaires.

The purpose of this research study is to test a new process for diagnosing lung cancer by examining changes to your DNA that can be detected from a blood test. The information we learn by doing this study could potentially help people in the future. Participants in this study will have blood samples collected, have their medical records reviewed by study personnel and fill out questionnaires at different time points during the study. Blood sample collection will occur during normal routine clinic visits. Participation in this study will last approximately 5 years.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Age 18 or older.
  • Get care at University of Maryland Baltimore Washington Medical Center.
  • Willing and able to agree to the study procedures.
  • Can speak and understand English.

Who can't join

  • Younger than 18.
  • Do not get care at University of Maryland Baltimore Washington Medical Center.
  • Unable to agree to the study procedures.
  • Unable to speak or understand English.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * 18 years old or older * Patient at University of Maryland Baltimore Washington Medical Center * Willing and able to consent to study procedures listed in the protocol * Ability to speak and understand English Exclusion Criteria: * Younger than 18 years old * Patient not cared for at University of Maryland Baltimore Washington Medical Center * Unable to consent to study procedures listed in the protocol * Unable to speak or understand English

Study sites (1)

MD

  • University of Maryland Baltimore Washington Medical Center · Glen Burnie, MD 21061Jeffrey Marshall, MD · Study contact · 410-787-4000 · Jeffrey.Marshall@umm.eduJeffrey Marshall, MD · Principal investigatorPeter Olivieri, MD · Sub-investigatorDarwin Ashbaker, MD · Sub-investigatorMore trials in Glen Burnie